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with that of his first hospitalization under the replacement therapy with FVII. The bruisings and 
hematomas had retired.
Conclusions: If a child especially if is a male has hemarthrosis in the large joints, had to be 
considered the possibility of having a coagulopathy even if he has no positive family history of any kind 
of coagulopathy.
Hemophilia A has an outburst evolution, their frequency is related to the concentration of the 
Factor VIII which is why the patient will require chronic replacement therapy with the avoidance of 
exercises and traumas.
Under the correct treatment, in terms of continuous prophylactic substitutions, life expectancy 
and quality of life was greatly improved, the risk of death caused by cerebral hemorrhage, internal 
bleeding or hemorrhagic shock had reduced to below 3 % of all the patients. 
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Introduction: Aplastic anemia is a rare disease in which the bone marrow and the hematopoietic 
stem cells that reside there are damaged. This causes a deficiency of all three blood cell types 
(pancytopenia). Aplastic refers to the inability of the stem cells to generate mature blood cells.
Aplastic anemia can be caused by exposure to certain chemicals, drugs, radiation, infection, 
immune disease, and heredity; in about half the cases, the cause is unknown. It may also occur due to a 
congenital inheritance or as well in the context of a constitutional predisposition.
Objective: The aim of this paper is to present the case of a 17 years old boy who developed 
aplastic anemia in the context of using sodium metamizol at home (Algocalmin) for 10 days without 
medical advice. Due to poor immune system the opportunistic fungus Aspergillus takes advantage of 
this situation and colonizes throughout the body leading to the condition called Aspersilosis.
Clinical case: We monitored the patient for a period of 33 days correspondently to the 
hospitalization in our Pediatric Clinic I - Hemato-Oncology Department of Targu-Mures.
Results: At the admission in our clinic, the first lab tests showed: a marked leukopenia 
(Leu/mm3- 440, Gran. 7/mm3) and trombocytopenia (PLT/mm3- 26.000) and the peripheral blood smear
showed (Segmented 0%, Eo 0%, Ba 0%, Mo 1%, Lymphocytes 99%). The final diagnose was 
established on the bone marrow biopsy histopathology exam. Than it was performed the Anti Aspergillus 
fumigatus antibody: 1/320 (NV< 1/80) because of the persisting fever. Immediately it was implemented
the antibiotic, antifungal and replacement therapy with a good result. After 33 days of hospitalization 
the lab tests showed a marked improvement therefore: the leucocytes reached the peak of 5890/mm3,
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granulocytes 4090/mm3, PLT 384.000/mm 3.
Conclusions: Due to the fact that the aplastic anemia is secondary to the treatment with 
Algocalmin occurred in a previously healthy young patient, the bone marrow rehabilitation was achieved 
with the right treatment.
After 6 months after the discharge, the patient had been declared completely cured having both 
aplastic anemia and systemic aspergillosis extinguished.
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Introduction: Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally 
responsible for producing antibodies.
In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow,
where they interfere with the production of normal blood cells. Most cases of multiple myeloma also 
feature the production of a paraprotein - an abnormal antibody which can cause bone lesions 
and hypercalcemia. Plasmacytoma refers to a tumour consisting of abnormal plasma cells that grows 
within the soft tissue or bony skeleton in the context of multiple myeloma disease.
Objective: We will present the case of a 56 years old female patient admitted in the Medical Clinic I -
Department of Hematology of Targu Mures, suffering from a rare hematological cancer - multiple 
myeloma of which onset was the appearance of a solitary extramedullary gigantic frontoparietal 
plasmacytoma which also did not responded at all to chemo-and radiotherapy treatment still increasing 
its size.
Clinical case: We monitored the patient over a period of 13 months and we will display the 
evolution chronologically.
Results: She was given 3 regimens of chemotherapy consisted in VAD, (Vincristine, 
Adriamycin, Dexamethasone), 7 regiments of PAD (Adriamycin, Epirubicin, Dexa.), one regimen of 
Velcade+Cytarabin+Dexamethasone in order to shrink the plasmacytoma but with no success. In the fall 
of 2015 she was presented at the oncology clinic for the administration of the radiotherapeutic regiments. 
After she recived a few radiotherapy still no reduction in the plasmacytoma volume. The oncologists 
stopped the therapy because the side effects were more significant than the improvements. The patient 
is currently hospitalized in our Hematology Clinic under the new treatment recently introduced with 
Caelix+Dexamethasone in order to reduce the level of plasma cells and the size of the frontoparietal 
plasmacytoma.
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